4//SEC Filing
MEMORY PHARMACEUTICALS CORP 4
Accession 0001209191-09-001355
CIK 0001062216operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:03 PM ET
Size
12.9 KB
Accession
0001209191-09-001355
Insider Transaction Report
Form 4
MPM BioVentures IV GP LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−14,138,993$8,624,786→ 0 total(indirect: See Footnote)
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−14,138,993$8,624,786→ 0 total(indirect: See Footnote)
MPM BioVentures IV QP LP
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−14,138,993$8,624,786→ 0 total(indirect: See Footnote)
MPM BioVentures IV LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−14,138,993$8,624,786→ 0 total(indirect: See Footnote)
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−14,138,993$8,624,786→ 0 total(indirect: See Footnote)
Footnotes (1)
- [F1]Shares tendered as follows: 13,251,643 shares by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 376,819 shares by MPM Asset Management Investors BV4 LLC ("AM BV4") and 510,531 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV IV LLC") are the direct and indirect general partners of BV IV QP and BV KG and BV IV LLC is the manager of AM BV4. Vaughn M. Kailian, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski and John VanderVort are members of BV IV LLC. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeoperating
Related Parties
1- filerCIK 0001062216
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:03 PM ET
- Size
- 12.9 KB